• Please log in or register to access this feature.

Viral Hepatitis

You have full text access to this OnlineOpen article

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine†

  1. Pietro Lampertico1,
  2. Mauro Viganò1,
  3. Elena Manenti1,
  4. Massimo Iavarone1,
  5. Giovanna Lunghi2,
  6. Massimo Colombo1,‡,*

Article first published online: 29 NOV 2005

DOI: 10.1002/hep.20939

Issue

Hepatology

Hepatology

Volume 42, Issue 6, pages 1414–1419, December 2005

Additional Information

How to Cite

Lampertico, P., Viganò, M., Manenti, E., Iavarone, M., Lunghi, G. and Colombo, M. (2005), Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Hepatology, 42: 1414–1419. doi: 10.1002/hep.20939

Author Information

  1. 1

    Department of Gastroenterology and Endocrinology, A. M. and A. Migliavacca Center for Liver Disease, IRCCS Maggiore Hospital, Fondazione Policlinico, Mangiagalli e Regina Elena, University of Milan, Milan, Italy

  2. 2

    Division of Hygiene, IRCCS Maggiore Hospital, Fondazione Policlinico, Mangiagalli e Regina Elena, University of Milan, Milan, Italy

  1. ‡

    fax: (39) 0250320410

*Department of Gastroenterology and Endocrinology, IRCCS Maggiore Hospital, University of Milan, Via F. Sforza 35-20122, Milan, Italy

  1. †

    Potential conflict of interest: Nothing to report.

  2. ‡

    fax: (39) 0250320410

Publication History

  1. Issue published online: 29 NOV 2005
  2. Article first published online: 29 NOV 2005
  3. Manuscript Accepted: 4 SEP 2005
  4. Manuscript Received: 12 MAY 2005

Funded by

  • Consorzio Interuniversitario Trapianti d'Organo, Rome, FIRST 2004, IRCCS Maggiore Hospital RF 2002

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (135K)

References

  • 1
    de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N; EASL Jury. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement. J Hepatol 2003; 39: S3-S25.
  • 2
    Lok ASF, McMahon BJ. Chronic hepatitis B: update of recommendations. HEPATOLOGY 2004; 39: 857-861.
    Direct Link:
  • 3
    Hadziyannis SJ, Papatheodoridis GV, Dimou E, Laras A, Papaioannou C. Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B. HEPATOLOGY 2000; 32: 847-851.
    Direct Link:
  • 4
    Papatheodoridis GV, Dimou E, Laras A, Papadimitropoulos V, Hadziyannis SJ. Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease. HEPATOLOGY 2002; 36: 219-226.
    Direct Link:
  • 5
    Rizzetto M, Tassopoulos NC, Goldin RD, Esteban R, Santantonio T, Heathcote EJ, et al. Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B. J Hepatol 2005; 42: 173-179.
  • 6
    Di Marco V, Marzano A, Lampertico P, Andreone P, Santantonio T, Almasio PL, et al. Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine. HEPATOLOGY 2004; 40: 883-891.
    Direct Link:
  • 7
    Perrillo R, Hann HW, Mutimer D, Willems B, Leung N, Lee WM, et al. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology 2004; 126: 81-91.
  • 8
    Peters MG, Hann HW, Martin P, Heathcote EJ, Buggisch P, Rubin R, et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology 2004; 126: 91-101.
  • 9
    Schiff ER, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. HEPATOLOGY 2003; 38: 1419-1427.
  • 10
    Vassiliadis T, Nikolaidis N, Giouleme O, Tziomalos K, Grammatikos N, Patsiaoura K, et al. Adefovir dipivoxil added to ongoing lamivudine therapy in patients with lamivudine-resistant hepatitis B e antigen-negative chronic hepatitis B. Aliment Pharmacol Ther 2005; 21: 531-537.
    Direct Link:
  • 11
    Hadziyannis S, Tassopoulos N, Chang TT, Heathcote J, Kitis G, Rizzetto M, et al. Adefovir dipivoxil (ADV) demonstrates sustained efficacy in HBeAg-negative chronic hepatitis B (CHB) patients [Abstract]. J Hepatol 2005; 42(Suppl 2): 178A.
  • 12
    Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003; 348: 808-816.
  • 13
    Manesis EK, Hadziyannis SJ. Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B. Gastroenterology 2001; 121: 101-109.
  • 14
    Lampertico P, Del Ninno E, Viganó M, Romeo R, Donato MF, Sablon E, et al. Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy. HEPATOLOGY 2003; 37: 756-763.
    Direct Link:
  • 15
    Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 2003; 348: 800-807.
  • 16
    Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001; 35: 421-430.
  • 17
    Stuyver L, Van Geyt C, De Gendt S, Van Reybroeck G, Zoulim F, Leroux-Roels G, et al. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol 2000; 38: 702-707.
  • 18
    Angus P, Vaughan R, Xiong S, Yang H, Delaney W, Gibbs C, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 2003; 125: 292-297.
  • 19
    Villeneuve JP, Durantel D, Durantel S, Westland C, Xiong S, Brosgart CL, et al. Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient. J Hepatol 2003; 39: 1085-1089.
  • 20
    Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
  • 21
    Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto P, Monti Gorin J, et al. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 2002; 36: 263-270.
  • 22
    Benhamou Y, Bonyhay L. Treatment of hepatitis B virus infection in patients coinfected with HIV. Gastroenterol Clin North Am 2004; 33: 617-627.
  • 23
    Shaw T, Bowden S, Locarnini S. Rescue therapy for drug resistant hepatitis B: another argument for combination chemotherapy? Gastroenterology 2004; 126: 343-350.
View Full Article (HTML) Get PDF (135K)